Projects funded by the NCN
Application of small compounds in the epigenetic therapy of malignant brain gliomas
2020/37/B/NZ5/03249
Keywords:
cannabidiol tetrahydrocannabinol,valproic acid metformin,dexamethasone temozolomide,8-OH-dG 5-methylocytosine glioma biomarker epigenetics senescence cancer stem cells beta-galactosidase Jmjd3 Utx
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Chemii Bioorganicznej Polskiej Akademii Nauk
woj. wielkopolskie
Principal investigator (from the host institution):
prof. Mirosława Naskręt-Barciszewska
Number of co-investigators in the project: 5
Call: OPUS 19 - announced on 2020-03-16
Amount awarded: 973 200 PLN
Project start date (Y-m-d): 2021-02-01
Project end date (Y-m-d): 2024-01-31
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.